[{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.117.1.7.1.134","meta":{"versionId":"24","lastUpdated":"2023-12-21T17:43:03.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2015-04-30"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.134","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.117.1.7.1.134"}],"version":"20150430","name":"OralFactorXaInhibitorForVTEProphylaxisOrVTETreatment","title":"Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment","status":"retired","experimental":false,"date":"2015-04-30T01:00:08-04:00","publisher":"TJC EH Steward","expansion":{"identifier":"urn:uuid:597eb690-997e-4129-bf55-68dc81604dfb","timestamp":"2024-02-11T11:07:01-05:00","total":5,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"01022024","code":"1114198","display":"rivaroxaban 10 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"01022024","code":"1232082","display":"rivaroxaban 15 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"01022024","code":"1232086","display":"rivaroxaban 20 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"01022024","code":"1364435","display":"apixaban 2.5 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"01022024","code":"1364445","display":"apixaban 5 MG Oral Tablet"}]}}]
